王秀强

This profile gathers the share dealings of 王秀强 in 拓新药业, where the filings describe the role as chief executive. Between 5 December 2022 and 8 December 2022, the trades on record add up to 2 filings.

Sales make up the whole of the open-market record (2 sales, €2.2M).

On 8 December 2022 came the latest disclosure, an open-market sale for €1.4M in 拓新药业. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.